Back to search

Aristotle University Of Thessaloniki (AUTH)

Μελέτη των ιστικών προγονικών κυττάρων του μυοκαρδίου και παραγόντων ίνωσης σε ασθενείς με αποφρακτική υπερτροφική μυοκαρδιοπάθεια

Abstract

dc:description

Hypertrophic cardiomyopathy (HCM) is the most prevalent genetic cardiac disorder characterized by hallmark histopathological features including cardiomyocyte hypertrophy and fibrosis. The interplay between cardiomyocytes and extracellular matrix (ECM) remains incompletely understood, but a growing body of evidence implicates interstitial cells, ECM remodeling, and small vessel disease in disease progression. This study aimed to delve deeper into these processes by investigating the expression of key molecular markers: c-kit, periostin, and TCF-21, in hypertrophic, fetal, and normal myocardium. Myocardial tissue samples were procured from 39 HCM patients undergoing septal myectomy, 10 fetal hearts, and 5 adult non-cardiac death controls. Routine histopathology was employed to assess hallmark features and immunohistochemical staining was performed to assess the expression of c-kit, periostin, and TCF-21. Quantitative analysis of staining intensity and fibrosis extent was conducted using image analysis software. A significant overexpression of periostin, a matricellular protein, was observed in hypertrophic myocardium. Periostin expression co-localized with fibrotic areas. These findings suggest a pivotal role for periostin in ECM remodeling and the fibrotic response in HCM. Moreover, periostin expression was positively correlated with the extent of fibrosis and inversely correlated with left ventricular ejection fraction. Conversely, a marked underexpression of TCF-21, a transcription factor associated with resident fibroblast identity, was noted in hypertrophic myocardium compared to fetal and normal myocardium. Moreover, TCF-21 expression was inversely correlated with periostin. This decrease in TCF-21 expression is known to support the shift of activated fibroblasts to myofibroblasts, thereby promoting ongoing fibrosis. Additionally, TCF-21 expression was found to be increased in the walls of small vessels in HCM and correlated positively with the severity of luminal stenosis, suggesting a potential role in small vessel disease. Notably, c-kit-positive cells, often characterized as potential resident progenitor cells, were sparsely detected in hypertrophic myocardium and c-kit was primarily localized to inflammatory and endothelial cells suggesting that they may not represent a significant population of cardiac progenitor cells in HCM. Τhese results provide novel insights into the molecular mechanisms underlying myocardial fibrosis and small vessel disease in HCM. The differential expression of periostin and TCF-21, along with their correlations with clinical parameters, highlights potential therapeutic targets for mitigating fibrosis, improving cardiac function, and addressing small vessel disease in HCM patients.

Degree

thesis:*
Grantor dc:publisher
Aristotle University Of Thessaloniki (AUTH)
Year dc:date
2024

Author and committee

dc:creator, dc:contributor.*
Authors dc:creator
  • Ioakeimidis, Nikolaos
  • Ιωακειμίδης, Νικόλαος

Subjects

dc:subject × 23

Rights

Language dc:language
gre

Identifiers

dc:identifier.*
Identifier
10.12681/eadd/57758

Chain of custody

source
Harvested from
Greek National Archive of PhD Theses
Base URL
phdtheses.ekt.gr/eadd_oai/request
Last updated
2026-11-18
Source record
OAI-PMH GetRecord
citation

Ioakeimidis, Nikolaos; Ιωακειμίδης, Νικόλαος. Μελέτη των ιστικών προγονικών κυττάρων του μυοκαρδίου και παραγόντων ίνωσης σε ασθενείς με αποφρακτική υπερτροφική μυοκαρδιοπάθεια. Aristotle University Of Thessaloniki (AUTH), 2024. http://hdl.handle.net/10442/hedi/57758